These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34265537)

  • 1. Cardiac effects of rapid intravenous loading of lacosamide in patients with epilepsy.
    Kim HK; Lee H; Bae EK; Kim DW
    Epilepsy Res; 2021 Oct; 176():106710. PubMed ID: 34265537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Cardiovascular Concerns of Intravenous Lacosamide Therapy in Epilepsy Patients.
    Lu YT; Lin CH; Ho CJ; Hsu CW; Tsai MH
    Front Neurol; 2022; 13():891368. PubMed ID: 35860491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous lacosamide in seizure emergencies: Observations from a hospitalized in-patient adult population.
    d'Orsi G; Pascarella MG; Martino T; Carapelle E; Pacillo F; Di Claudio MT; Mancini D; Trivisano M; Avolio C; Specchio LM
    Seizure; 2016 Nov; 42():20-28. PubMed ID: 27693808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous lacosamide in clinical practice-Results from an independent registry.
    Lang N; Lange M; Schmitt FC; Bös M; Weber Y; Evers S; Burghaus L; Kellinghaus C; Schubert-Bast S; Bösel J; Lammers T; Sabolek M; van Baalen A; Dziewas R; Kraft A; Ruf S; Stephani U
    Seizure; 2016 Jul; 39():5-9. PubMed ID: 27161669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous lacosamide in refractory seizure clusters and status epilepticus: comparison of 200 and 400 mg loading doses.
    Legros B; Depondt C; Levy-Nogueira M; Ligot N; Mavroudakis N; Naeije G; Gaspard N
    Neurocrit Care; 2014 Jun; 20(3):484-8. PubMed ID: 23896816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
    Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
    Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of intravenous lacosamide in hospitalized children and neonates.
    Fong SL; Utidjian L; Kaur M; Abend NS; Wainwright MS; Grande KM; Foskett N; Roebling R; Guerriero RM; Jain B; Rao S; Stoltenberg M; Williams P; Yuen N; Dickinson K; McDonald J; Maltenfort M; Forrest CB
    Epilepsia; 2023 Sep; 64(9):2297-2309. PubMed ID: 37287398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of the dose and blood concentration of lacosamide in Japanese pediatric patients with epilepsy: A cohort study.
    Ishikawa N; Eguchi Y; Izumo H; Tateishi Y; Tani H; Kobayashi Y; Okada S
    Epilepsy Behav; 2022 Apr; 129():108614. PubMed ID: 35203014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Lacosamide in Seizure Clusters: Dose and Efficacy.
    Eilam A; Khmeliov N; Penker D; Gilad R
    Clin Neuropharmacol; 2021 May-Jun 01; 44(3):85-88. PubMed ID: 33811195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, tolerability, and pharmacokinetics of weight-based IV loading dose of lacosamide in the ICU.
    Chimakurthy AK; Ramsay RE; Sabharwal V; Menon U
    Epilepsy Behav; 2021 Jan; 114(Pt A):107449. PubMed ID: 32943331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: a comparative cohort study.
    Sutter R; Marsch S; Rüegg S
    CNS Drugs; 2013 Apr; 27(4):321-9. PubMed ID: 23533010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioembolic acute cerebral micro-infarcts in the context of atrial fibrillation after low-dose intravenous infusion of lacosamide.
    Corbellini ÁB; Torre PP; Hristova VN; Sanz BZ; García ACC; Jorge FR; García JLC; Díaz PP; Catevilla FJB
    Epileptic Disord; 2020 Feb; 22(1):83-89. PubMed ID: 32043469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacosamide-induced second-degree atrioventricular block in a patient with partial epilepsy.
    Nizam A; Mylavarapu K; Thomas D; Briskin K; Wu B; Saluja D; Wong S
    Epilepsia; 2011 Oct; 52(10):e153-5. PubMed ID: 21801173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrioventricular block following lacosamide intoxication.
    Krause LU; Brodowski KO; Kellinghaus C
    Epilepsy Behav; 2011 Apr; 20(4):725-7. PubMed ID: 21411374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy.
    Santamarina E; González-Cuevas M; Toledo M; Jiménez M; Becerra JL; Quílez A; Suller A; Mauri JA; Fernández Á; Marinas A; Quintana M; Puig XS
    Epilepsy Behav; 2018 Jul; 84():93-98. PubMed ID: 29758445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience of intravenous lacosamide in infants and young children.
    Arkilo D; Gustafson M; Ritter FJ
    Eur J Paediatr Neurol; 2016 Mar; 20(2):212-217. PubMed ID: 26810009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Safety and Effectiveness of Intravenous Lacosamide for Refractory Status Epilepticus in the Critically Ill.
    Newey CR; Le NM; Ahrens C; Sahota P; Hantus S
    Neurocrit Care; 2017 Apr; 26(2):273-279. PubMed ID: 27844464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose lacosamide-induced atrial fibrillation: Case analysis with literature review.
    Kaufman KR; Velez AE; Wong S; Mani R
    Epilepsy Behav Case Rep; 2013; 1():22-5. PubMed ID: 25688049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Lacosamide in refractory nonconvulsive status epilepticus.
    Mnatsakanyan L; Chung JM; Tsimerinov EI; Eliashiv DS
    Seizure; 2012 Apr; 21(3):198-201. PubMed ID: 22244046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.